Koios DS™ Breast
Smart Ultrasound software providing early and accurate breast cancer diagnosis.
FDA-Cleared • CE Marked • Billable Procedure
With a collection of algorithms utilizing over 2 million proprietary ultrasound images and analysis of over 17k features per image, the Koios DS Smart Ultrasound software uses AI to reliably classify and render breast cancer risk assessment.
Simplicity is key.
Koios decision support software integrates into most PACS workstations effectively taking malignancy risk assessment to the next level.
Select a region of interest for analysis.
In seconds, Koios DS analyzes and captures all nodule descriptors automatically and aligns to BI-RADS or ATA to dynamically calculate ratings.
Export the findings to a reporting system and save them as a secondary capture to PACS.
Research Proven
AJR conducted a study to assess the impact of artificial intelligence-based decision support (DS) on breast ultrasound lesion assessment.
The research concluded that AI-based DS improves accuracy of sonographic breast lesion assessment while reducing inter- and intraobserver variability.
Significantly improved diagnostic accuracy
Detected up to 6 more cancers per 100 interpreted
Potential to reduce benign biopsies up to 31%
AJR: American Journal of Roentgenology
More from Koios
Learn about our software solution for thyroid cancer detection.
